Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 7/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.77 |
| ▸ | MAPT | P10636 | 1/20 | 0.70 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.56 |
| ▸ | CNR1 | P21554 | 4/20 | 0.55 |
| ▸ | CNR2 | P34972 | 4/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | CASP2 | P42575 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4915736 | 1.00 | FAAH (1.00) | FAAHTSHRSMN1; SMN2MAPTDNM1 | |
| SCHEMBL3168889 | 1.00 | FAAH (1.00) | FAAHTSHRSMN1; SMN2MAPTDNM1 | |
| SCHEMBL4557099 | 1.00 | FAAH (1.00) | FAAHTSHRSMN1; SMN2MAPTDNM1 | |
| Hexadecanoic Acid Allylamide SCHEMBL4914176 | 1.00 | FAAH (1.00) | FAAHTSHRSMN1; SMN2MAPTDNM1 | |
| SCHEMBL5866879 | 1.00 | FAAH (1.00) | FAAHTSHRSMN1; SMN2MAPTDNM1 | |
| SCHEMBL30763460 | 1.00 | FAAH (1.00) | FAAHTSHRSMN1; SMN2MAPTDNM1 | |
| SCHEMBL8251669 | 1.00 | FAAH (1.00) | FAAHTSHRSMN1; SMN2MAPTDNM1 | |
| SCHEMBL4013783 | 1.00 | FAAH (1.00) | FAAHTSHRSMN1; SMN2MAPTDNM1 | |
| SCHEMBL4014444 | 1.00 | FAAH (1.00) | FAAHTSHRSMN1; SMN2MAPTDNM1 | |
| SCHEMBL28373906 | 0.98 | FAAH (0.96) | FAAHTSHRSMN1; SMN2MAPTDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080269325-A1 | Methods to Relieve Pain | IMPERIAL INNOVATIONS LIMITED (GB) | 2008-10-30 | — | — | US | claimed |
| EP-1722764-A1 | METHODS FOR RELIEF OF PAIN | Imperial Innovations Limited (GB) | 2006-11-22 | — | — | EP | claimed |
| WO-2005079771-A1 | METHODS TO RELIEF PAIN | IMPERIAL INNOVATIONS LIMITED (GB) | 2005-09-01 | — | — | WO | claimed |
| EP-2421877-A1 | ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE | Glycan Biosciences Pty Ltd (AU) | 2012-02-29 | — | — | EP | disclosed |
| WO-2010037179-A1 | ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE | GLYCAN BIOSCIENCES PTY LTD (AU) | 2010-04-08 | — | — | WO | disclosed |
| US-20080269325-A1 | Methods to Relieve Pain | IMPERIAL INNOVATIONS LIMITED (GB) | 2008-10-30 | — | — | US | disclosed |
| US-20080269325-A1 | Methods to Relieve Pain | IMPERIAL INNOVATIONS LIMITED (GB) | 2008-10-30 | — | — | US | disclosed |
| EP-1722764-A1 | METHODS FOR RELIEF OF PAIN | Imperial Innovations Limited (GB) | 2006-11-22 | — | — | EP | disclosed |
| WO-2005079771-A1 | METHODS TO RELIEF PAIN | IMPERIAL INNOVATIONS LIMITED (GB) | 2005-09-01 | — | — | WO | disclosed |
| EP-1083919-A1 | NOVEL ANTIVIRAL COMPOUNDS | Advanced Medicine, Inc. (US) | 2001-03-21 | — | — | EP | disclosed |
| EP-1083920-A1 | NOVEL ANTIBACTERIAL COMPOUNDS | Advanced Medicine, Inc. (US) | 2001-03-21 | — | — | EP | disclosed |
| EP-0989857-A4 | NOVEL THERAPEUTIC AGENTS THAT MODULATE ENZYMATIC PROCESSES | ADVANCED MEDICINE INC (US) | 2001-01-17 | — | — | EP | disclosed |
| WO-1999064038-A9 | NOVEL ANALGESIC AGENTS | ADVANCED MEDICINE INC (US) | 2000-05-04 | — | — | WO | disclosed |
| EP-0989857-A1 | NOVEL THERAPEUTIC AGENTS THAT MODULATE ENZYMATIC PROCESSES | Advanced Medicine, Inc. (US) | 2000-04-05 | — | — | EP | disclosed |
| WO-1999064047-A9 | NOVEL ANTIVIRAL COMPOUNDS | ADVANCED MEDICINE INC (US) | 2000-03-16 | — | — | WO | disclosed |
| WO-1999064038-A1 | NOVEL ANALGESIC AGENTS | ADVANCED MEDICINE, INC. (US) | 1999-12-16 | — | — | WO | disclosed |
| WO-1999064051-A1 | NOVEL ANTIBACTERIAL COMPOUNDS | ADVANCED MEDICINE, INC. (US) | 1999-12-16 | — | — | WO | disclosed |
| WO-1999064047-A1 | NOVEL ANTIVIRAL COMPOUNDS | ADVANCED MEDICINE, INC. (US) | 1999-12-16 | — | — | WO | disclosed |
| WO-1999064037-A1 | NOVEL THERAPEUTIC AGENTS THAT MODULATE ENZYMATIC PROCESSES | ADVANCED MEDICINE, INC. (US) | 1999-12-16 | — | — | WO | disclosed |
| WO-1999064044-A1 | NOVEL THERAPEUTIC AGENTS THAT MODULATE 5-HT RECEPTORS | ADVANCED MEDICINE, INC. (US) | 1999-12-16 | — | — | WO | disclosed |